Publications

Shantavasinkul, Prapimporn Ch, Philip Omotosho, Leonor Corsino, Michael J. Muehlbauer, Pairoj Chattranukulchai, and Alfonso Torquati. “Changes of Circulating Irisin and High-Sensitivity C-Reactive Protein Levels in Morbidly Obese Individuals with Type 2 Diabetes After Roux-en-Y Gastric Bypass.” In J Laparoendosc Adv Surg Tech A, 2022. https://doi.org/10.1089/lap.2021.0558.

PMID
35443789
Full Text

Handelsman, Yehuda, John E. Anderson, George L. Bakris, Christie M. Ballantyne, Joshua A. Beckman, Deepak L. Bhatt, Zachary T. Bloomgarden, et al. “DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases.” J Diabetes Complications 36, no. 2 (February 2022): 108101. https://doi.org/10.1016/j.jdiacomp.2021.108101.

PMID
34922811
Full Text

Nelson, Adam J., Emily C. O’Brien, Lisa A. Kaltenbach, Jennifer B. Green, Renato D. Lopes, Caryn G. Morse, Hussein R. Al-Khalidi, et al. “Use of Lipid-, Blood Pressure-, and Glucose-Lowering Pharmacotherapy in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease.” Jama Netw Open 5, no. 2 (February 1, 2022): e2148030. https://doi.org/10.1001/jamanetworkopen.2021.48030.

PMID
35175345
Full Text

D’Alessio, David, and Cris Slentz. “Data from: GLP-1 receptor blockade reduces stimulated insulin secretion in fasted subjects with low circulating GLP-1,” January 26, 2022. https://doi.org/10.7924/r47s7t64c.

Full Text

Williams, Ashley S., Timothy R. Koves, Yasminye D. Pettway, James A. Draper, Dorothy H. Slentz, Paul A. Grimsrud, Olga R. Ilkayeva, and Deborah M. Muoio. “Nicotinamide riboside supplementation confers marginal metabolic benefits in obese mice without remodeling the muscle acetyl-proteome.” Iscience 25, no. 1 (January 21, 2022): 103635. https://doi.org/10.1016/j.isci.2021.103635.

PMID
35028529
Full Text

Pirro, Valentina, Kenneth D. Roth, Yanzhu Lin, Jill A. Willency, Paul L. Milligan, Jonathan M. Wilson, Giacomo Ruotolo, Axel Haupt, Christopher B. Newgard, and Kevin L. Duffin. “Effects of Tirzepatide, a Dual GIP and GLP-1 RA, on Lipid and Metabolite Profiles in Subjects With Type 2 Diabetes.” J Clin Endocrinol Metab 107, no. 2 (January 18, 2022): 363–78. https://doi.org/10.1210/clinem/dgab722.

PMID
34608929
Full Text

Tripathi, Madhulika, Brijesh Kumar Singh, Elisa A. Liehn, Sheau Yng Lim, Keziah Tikno, David Castano-Mayan, Chutima Rattanasopa, et al. “Caffeine prevents restenosis and inhibits vascular smooth muscle cell proliferation through the induction of autophagy.” Autophagy, January 11, 2022, 1–11. https://doi.org/10.1080/15548627.2021.2021494.

PMID
35012409
Full Text

Moon, Jee-Young, Simin Hua, Qibin Qi, Daniela Sotres-Alvarez, Josiemer Mattei, Sarah S. Casagrande, Yasmin Mossavar-Rahmani, et al. “Association of Sugar-Sweetened Beverage Consumption with Prediabetes and Glucose Metabolism Markers in Hispanic/Latino Adults in the United States: Results from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).” J Nutr 152, no. 1 (January 11, 2022): 235–45. https://doi.org/10.1093/jn/nxab334.

PMID
34558625
Full Text

Gill, Nathan P., Raji Balasubramanian, James R. Bain, Michael J. Muehlbauer, William L. Lowe, and Denise M. Scholtens. “Path-level interpretation of Gaussian graphical models using the pair-path subscore.” Bmc Bioinformatics 23, no. 1 (January 5, 2022): 12. https://doi.org/10.1186/s12859-021-04542-5.

PMID
34986802
Full Text

Verma, Subodh, Nitish K. Dhingra, Javed Butler, Stefan D. Anker, Joao Pedro Ferreira, Gerasimos Filippatos, James L. Januzzi, et al. “Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial.” Lancet Diabetes Endocrinol 10, no. 1 (January 2022): 35–45. https://doi.org/10.1016/S2213-8587(21)00292-8.

PMID
34861154
Full Text

Pages